Combined Central and Peripheral Demyelinating Disease With Good Response to B-Cell Depleting Therapy. [PDF]
Makkawi S +3 more
europepmc +1 more source
Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence [PDF]
Buchmeier, M J +3 more
core
Olfactory Pathology in Central Nervous System Demyelinating Diseases
Gabriele C. DeLuca +6 more
openalex +2 more sources
Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease [PDF]
Hiroyuki Yahikozawa +4 more
openalex +1 more source
ABSTRACT Background Mitofusin 2 (MFN2) is a major causative gene for axonal Charcot – Marie – Tooth disease type 2A (CMT2A), with a wide phenotypic spectrum. Comprehensive large ‐ scale genotype – phenotype association studies are essential for understanding disease pathogenesis and improved clinical management.
Masahiro Ando +13 more
wiley +1 more source
Exploring the Role of Platelets in Virus-Induced Inflammatory Demyelinating Disease and Myocarditis. [PDF]
Ahmad I +8 more
europepmc +1 more source
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease. [PDF]
Sun W +6 more
europepmc +1 more source
Repurposing of Chemokine Antagonists for Combined Phase‐Resolved Spinal Cord Injury Treatment
Spinal cord injury (SCI) in mammals is accompanied by a massive cytokine storm in cerebrospinal fluid, mainly driven by CXCL1, IL‐6, and CCL2‐5. Sub‐acute phase is mostly associated with IL‐2, IL‐7, CCL22, and CX3CL1, whereas TNFα and IL17α permanently persists in CNS even weeks following SCI.
Alexey A. Belogurov Jr. +20 more
wiley +1 more source

